MacConell L - Search Results

1

Association among weight change, glycemic control, and markers of cardiovascular risk with exenatide once weekly: a pooled analysis of patients with type 2 diabetes.

Blonde L, Pencek R, MacConell L. Blonde L, et al. Among authors: macconell l. Cardiovasc Diabetol. 2015 Feb 3;14:12. doi: 10.1186/s12933-014-0171-2. Cardiovasc Diabetol. 2015. PMID: 25645567 Free PMC article. Clinical Trial.

2

Comparison of safety and tolerability with continuous (exenatide once weekly) or intermittent (exenatide twice daily) GLP-1 receptor agonism in patients with type 2 diabetes.

Ridge T, Moretto T, MacConell L, Pencek R, Han J, Schulteis C, Porter L. Ridge T, et al. Among authors: macconell l. Diabetes Obes Metab. 2012 Dec;14(12):1097-103. doi: 10.1111/j.1463-1326.2012.01639.x. Epub 2012 Jul 19. Diabetes Obes Metab. 2012. PMID: 22734440 Free PMC article.

3

Exenatide once weekly: sustained improvement in glycemic control and cardiometabolic measures through 3 years.

Macconell L, Pencek R, Li Y, Maggs D, Porter L. Macconell L, et al. Diabetes Metab Syndr Obes. 2013;6:31-41. doi: 10.2147/DMSO.S35801. Epub 2013 Jan 21. Diabetes Metab Syndr Obes. 2013. PMID: 23358123 Free PMC article.

4

Addition of exenatide BID to insulin glargine: a post-hoc analysis of the effect on glycemia and weight across a range of insulin titration.

Buse JB, Han J, Miller S, MacConell L, Pencek R, Wintle M. Buse JB, et al. Among authors: macconell l. Curr Med Res Opin. 2014 Jul;30(7):1209-18. doi: 10.1185/03007995.2014.896329. Epub 2014 Mar 18. Curr Med Res Opin. 2014. PMID: 24621255 Clinical Trial.

5

Obeticholic acid is associated with improvements in AST-to-platelet ratio index and GLOBE score in patients with primary biliary cholangitis.

Harms MH, Hirschfield GM, Floreani A, Mayo MJ, Parés A, Liberman A, Malecha ES, Pencek R, MacConell L, Hansen BE. Harms MH, et al. Among authors: macconell l. JHEP Rep. 2020 Sep 29;3(1):100191. doi: 10.1016/j.jhepr.2020.100191. eCollection 2021 Feb. JHEP Rep. 2020. PMID: 33319187 Free PMC article.

6

Long-Term Obeticholic Acid Therapy Improves Histological Endpoints in Patients With Primary Biliary Cholangitis.

Bowlus CL, Pockros PJ, Kremer AE, Parés A, Forman LM, Drenth JPH, Ryder SD, Terracciano L, Jin Y, Liberman A, Pencek R, Iloeje U, MacConell L, Bedossa P. Bowlus CL, et al. Among authors: macconell l. Clin Gastroenterol Hepatol. 2020 May;18(5):1170-1178.e6. doi: 10.1016/j.cgh.2019.09.050. Epub 2019 Oct 10. Clin Gastroenterol Hepatol. 2020. PMID: 31606455 Clinical Trial.

7

A randomized, placebo-controlled, phase II study of obeticholic acid for primary sclerosing cholangitis.

Kowdley KV, Vuppalanchi R, Levy C, Floreani A, Andreone P, LaRusso NF, Shrestha R, Trotter J, Goldberg D, Rushbrook S, Hirschfield GM, Schiano T, Jin Y, Pencek R, MacConell L, Shapiro D, Bowlus CL; AESOP Study Investigators. Kowdley KV, et al. Among authors: macconell l. J Hepatol. 2020 Jul;73(1):94-101. doi: 10.1016/j.jhep.2020.02.033. Epub 2020 Mar 10. J Hepatol. 2020. PMID: 32165251 Free PMC article. Clinical Trial.

8

Efficacy and Safety of Multiple Doses of Exenatide Once-Monthly Suspension in Patients With Type 2 Diabetes: A Phase II Randomized Clinical Trial.

Wysham CH, MacConell L, Hardy E. Wysham CH, et al. Among authors: macconell l. Diabetes Care. 2016 Oct;39(10):1768-76. doi: 10.2337/dc16-0238. Epub 2016 Jul 19. Diabetes Care. 2016. PMID: 27436275 Clinical Trial.

9

Five-year efficacy and safety data of exenatide once weekly: long-term results from the DURATION-1 randomized clinical trial.

Wysham CH, MacConell LA, Maggs DG, Zhou M, Griffin PS, Trautmann ME. Wysham CH, et al. Mayo Clin Proc. 2015 Mar;90(3):356-65. doi: 10.1016/j.mayocp.2015.01.008. Mayo Clin Proc. 2015. PMID: 25744115 Clinical Trial.

10

Clinical application of the GLOBE and United Kingdom-primary biliary cholangitis risk scores in a trial cohort of patients with primary biliary cholangitis.

Carbone M, Harms MH, Lammers WJ, Marmon T, Pencek R, MacConell L, Shapiro D, Jones DE, Mells GF, Hansen BE. Carbone M, et al. Among authors: macconell l. Hepatol Commun. 2018 Apr 19;2(6):683-692. doi: 10.1002/hep4.1180. eCollection 2018 Jun. Hepatol Commun. 2018. PMID: 29881820 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

47 results

Search Page